Results 101 to 110 of about 62,041 (172)

Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors-In Silico Activity Prediction. [PDF]

Int J Mol Sci, 2018
Dąbrowska A, Pieńko T, Taciak P, Wiktorska K, Chilmonczyk Z, Mazurek AP, Stasiulewicz A.   +6 more
europepmc   +1 more source

A highly sensitive aptamer-based HIV reverse transcriptase detection assay. [PDF]

J Virol Methods, 2018
DeStefano JJ, Alves Ferreira-Bravo I.
europepmc   +1 more source

Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors. [PDF]

Viruses
Costa-Tuna A, Chaves OA, Almeida ZL, Cunha RS, Pina J, Serpa C.   +5 more
europepmc   +1 more source

Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir. [PDF]

J Biol Chem, 2017
Toksoy A, Sennefelder H, Adam C, Hofmann S, Trautmann A, Goebeler M, Schmidt M.   +6 more
europepmc   +1 more source

Proposal of pharmacophore model for HIV reverse transcriptase inhibitors: Combined mutational effect analysis, molecular dynamics, molecular docking and pharmacophore modeling study. [PDF]

Int J Immunopathol Pharmacol
Annan A, Raiss N, Lemrabet S, Elomari N, Elmir EH, Filali-Maltouf A, Medraoui L, Oumzil H.   +7 more
europepmc   +1 more source

Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity. [PDF]

J Biol Chem, 2016
Li A, Gong S, Johnson KA.
europepmc   +1 more source

Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase. [PDF]

J Mol Biol, 2018
Ilina TV, Slack RL, Elder JH, Sarafianos SG, Parniak MA, Ishima R.   +5 more
europepmc   +1 more source

HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection. [PDF]

Sci Rep, 2018
Cantão NM, Fogaça de Almeida L, Rodrigo Wolf I, Oliveira Almeida R, Alves de Almeida Cruz A, Nunes C, Barbosa AN, Valente GT, de Moura Campos Pardini MI, Grotto RMT.   +9 more
europepmc   +1 more source

Synthetic α-Hydroxytropolones as Inhibitors of HIV Reverse Transcriptase Ribonuclease H Activity. [PDF]

Medchemcomm, 2016
Murelli RP, D'Erasmo MP, Hirsch DR, Meck C, Masaoka T, Wilson JA, Zhang B, Pal RK, Gallicchio E, Beutler JA, Le Grice SF.   +10 more
europepmc   +1 more source

Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. [PDF]

Eur J Med Chem, 2019
Tang J, Do HT, Huber AD, Casey MC, Kirby KA, Wilson DJ, Kankanala J, Parniak MA, Sarafianos SG, Wang Z.   +9 more
europepmc   +1 more source